Cultrex Basement Membrane Extract, PathClear

Basement Membrane Extract for use in multiple culture applications
Catalog # Availability Size / Price Qty
3432-001-01
3432-005-01
3432-010-01
Cultrex Basement Membrane Extract
1 Image
Product Details
Citations (32)
FAQs
Reviews (3)

Cultrex Basement Membrane Extract, PathClear Summary

Cultrex Basement Membrane Extract (BME) is an extracellular matrix hydrogel that has been used extensively in general cell culture applications to study cell attachment, proliferation, and invasion.

Key Benefits

• Ideal for general cell culture application
• Polymerizes at 37°C to form a reconstituted basement membrane
• Quality controlled for peformance consistency

Why Use Cultrex BME?

Cultrex Basement Membrane Extract (BME) is a soluble form of basement membrane purified from Engelbreth-Holm-Swarm (EHS) tumor. This extract provides a natural extracellular matrix hydrogel that polymerizes at 37°C to form a reconstituted basement membrane. Cultrex BME can be used in multiple applications, including maintaining growth or promoting differentiation of primary endothelial, epithelial, smooth muscle, stem cells, and organoid/3-D cell cultures. It can also be utilized in cell attachment, neurite outgrowth, angiogenesis, in vitro cell invasion, and in vivo tumorigenicity assays.

Basement membranes are continuous sheets of specialized extracellular matrix that form an interface between endothelial, epithelial, muscle, or neuronal cells and their adjacent stroma and that play an essential role in tissue organization by influencing cell adhesion, migration, proliferation, and differentiation. The major components of BME include laminin, collagen IV, entactin, and heparin sulfate proteoglycans.

Specifications

Source
Murine Engelbreth-Holm-Swarm (EHS) tumor
Protein Concentration
8-12 mg/mL as determined by Lowry assay
Endotoxin Level
≤ 8 EU/mL by Limulus Amoebocyte Lysate (LAL) assay
Sterility Testing
Tested following USP <71> sterility guidelines.
Testing Cell Culture
Tube Formation Assay - Cultrex BME supports formation of capillary-like structures by human (HBMVEC; HUVEC) or mouse (SVEC4-10) endothelial cells in a tube formation assay.

Gelling Assay - Cultrex BME gels in less than 30 minutes at 37 °C, and maintains the gelled form in culture medium for a minimum of 14 days at 37 °C.
Viral Testing
Tested negative by PCR test for a total of 31 organisms and viruses, including: mycoplasma, 17 bacterial and virus strains typically included in mouse antibody production (MAP) testing, and 13 additional murine infectious agents including LDEV.
Stability
Product is stable for at least 3 months from the date of receipt when stored at ≤ -70 °C. See lot specific Certificate of Analysis for expiration date.
Shipping Conditions
The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended on the product label.
Storage
Store the unopened product at -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Species
Mouse

Limitations

For research use only. Not for diagnositic use.

Product Datasheets

Citations for Cultrex Basement Membrane Extract, PathClear

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

32 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Specific and Non-Invasive Fluorescent Labelling of Extracellular Vesicles for Evaluation of Intracellular Processing by Intestinal Epithelial Cells
    Authors: MS Hansen, ISE Gadegaard, EC Arnspang, K Blans, LN Nejsum, JT Rasmussen
    Biomedicines, 2020;8(7):.  2020
  2. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation
    Authors: BL Baechler, D Bloemberg, J Quadrilate
    Autophagy, 2019;0(0):.  2019
  3. Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression
    Proc. Natl. Acad. Sci. U.S.A., 2016;0(0):.  2016
  4. Wnt signaling promotes breast cancer by blocking ITCH-mediated degradation of the YAP/TAZ transcriptional coactivator WBP2
    Cancer Res, 2016;0(0):.  2016
  5. Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
    Authors: Sameni M, Tovar E, Essenburg C, Chalasani A, Linklater E, Borgman A, Cherba D, Anbalagan A, Winn M, Graveel C, Sloane B
    Clin Cancer Res, 2015;22(4):923-34.  2015
  6. Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth.
    Authors: Caccuri, Francesc, Giagulli, Cinzia, Reichelt, Joachim, Martorelli, Debora, Marsico, Stefania, Bugatti, Antonell, Barone, Ines, Rusnati, Marco, Guzman, Carlos A, Dolcetti, Riccardo, Caruso, Arnaldo
    J Virol, 2014;88(10):5706-17.  2014
  7. The M33 G protein-coupled receptor encoded by murine cytomegalovirus is dispensable for hematogenous dissemination but is required for growth within the salivary gland.
    Authors: Bittencourt F, Wu S, Bridges J, Miller W
    J Virol, 2014;88(20):11811-24.  2014
  8. Suppression of ERbeta signaling via ERbeta knockout or antagonist protects against bladder cancer development.
    Authors: Hsu I, Chuang K, Slavin S, Da J, Lim W, Pang S, O'Brien J, Yeh S
    Carcinogenesis, 0;35(3):651-61.  0
  9. PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells.
    Authors: Kolev V, Wright Q, Vidal C, Ring J, Shapiro I, Ricono J, Weaver D, Padval M, Pachter J, Xu Q
    Cancer Res, 0;75(2):446-55.  0
  10. Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody.
    Authors: Traini S, Piccolo E, Tinari N, Rossi C, La Sorda R, Spinella F, Bagnato A, Lattanzio R, D'Egidio M, Di Risio A, Tomao F, Grassadonia A, Piantelli M, Natoli C, Iacobelli S
    Mol Cancer Ther, 0;13(4):916-25.  0
  11. Dickkopf-3 regulates prostate epithelial cell acinar morphogenesis and prostate cancer cell invasion by limiting TGF-beta-dependent activation of matrix metalloproteases.
    Authors: Romero D, Al-Shareef Z, Gorrono-Etxebarria I, Atkins S, Turrell F, Chhetri J, Bengoa-Vergniory N, Zenzmaier C, Berger P, Waxman J, Kypta R
    Carcinogenesis, 0;37(1):18-29.  0
  12. Regulation of P21-activated kinase-4 by progesterone and tumor necrosis factor-alpha in human endometrium and its increased expression in advanced-stage endometriosis.
    Authors: Kim S, Kim S, Ihm H, Oh Y, Chae H, Kim C, Kang B
    J Clin Endocrinol Metab, 0;98(2):E238-48.  0
  13. Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.
    Authors: Munson J, Fried L, Rowson S, Bonner M, Karumbaiah L, Diaz B, Courtneidge S, Knaus U, Brat D, Arbiser J, Bellamkonda R
    Sci Transl Med, 0;4(127):127ra36.  0
  14. p16 controls epithelial cell growth and suppresses carcinogenesis through mechanisms that do not require RB1 function.
    Authors: Sen M, Akeno N, Reece A, Miller A, Simpson D, Wikenheiser-Brokamp K
    Oncogenesis, 0;6(4):e320.  0
  15. A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment.
    Authors: Zhang W, Dang S, Hong T, Tang J, Fan J, Bu D, Sun Y, Wang Z, Wisniewski T
    Blood, 0;120(14):2889-98.  0
  16. Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2.
    Authors: Cieply B, Riley P, Pifer P, Widmeyer J, Addison J, Ivanov A, Denvir J, Frisch S
    Cancer Res, 0;72(9):2440-53.  0
  17. MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells.
    Authors: Beke L, Kig C, Linders J, Boens S, Boeckx A, van Heerde E, Parade M, De Bondt A, Van den Wyngaert I, Bashir T, Ogata S, Meerpoel L, Van Eynde A, Johnson C, Beullens M, Brehmer D, Bollen M
    Biosci Rep, 0;35(6):.  0
  18. The MEF2-HDAC axis controls proliferation of mammary epithelial cells and acini formation in vitro.
    Authors: Clocchiatti A, Di Giorgio E, Viviani G, Streuli C, Sgorbissa A, Picco R, Cutano V, Brancolini C
    J Cell Sci, 0;128(21):3961-76.  0
  19. HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.
    Authors: Caccuri F, Giagulli C, Bugatti A, Benetti A, Alessandri G, Ribatti D, Marsico S, Apostoli P, Slevin M, Rusnati M, Guzman C, Fiorentini S, Caruso A
    Proc Natl Acad Sci U S A, 0;109(36):14580-5.  0
  20. Microfluidics separation reveals the stem-cell-like deformability of tumor-initiating cells.
    Authors: Zhang W, Kai K, Choi D, Iwamoto T, Nguyen Y, Wong H, Landis M, Ueno N, Chang J, Qin L
    Proc Natl Acad Sci U S A, 0;109(46):18707-12.  0
  21. Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells.
    Authors: Binda E, Visioli A, Giani F, Trivieri N, Palumbo O, Restelli S, Dezi F, Mazza T, Fusilli C, Legnani F, Carella M, Di Meco F, Duggal R, Vescovi A
    Cancer Res, 0;77(4):996-1007.  0
  22. Timing and targeting: the biological functions of Dam methylation in E. coli.
    Authors: Messer W, Noyer-Weidner M
    Cell, 0;54(6):735-7.  0
  23. Real-time monitoring of NKCC2 endocytosis by total internal reflection fluorescence (TIRF) microscopy.
    Authors: Jaykumar A, Caceres P, Sablaban I, Tannous B, Ortiz P
    Am J Physiol Renal Physiol, 0;310(2):F183-91.  0
  24. Cathepsin B inhibition limits bone metastasis in breast cancer.
    Authors: Withana N, Blum G, Sameni M, Slaney C, Anbalagan A, Olive M, Bidwell B, Edgington L, Wang L, Moin K, Sloane B, Anderson R, Bogyo M, Parker B
    Cancer Res, 0;72(5):1199-209.  0
  25. The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor.
    Authors: Spinella F, Caprara V, Cianfrocca R, Rosano L, Di Castro V, Garrafa E, Natali P, Bagnato A
    Carcinogenesis, 0;35(4):840-8.  0
  26. Mouse embryonic dorsal root ganglia contain pluripotent stem cells that show features similar to embryonic stem cells and induced pluripotent stem cells.
    Authors: Ogawa R, Fujita K, Ito K
    Biol Open, 0;6(5):602-618.  0
  27. Involvement of the heparanase procoagulant domain in bleeding and wound healing.
    Authors: Crispel Y, Ghanem S, Attias J, Kogan I, Brenner B, Nadir Y
    J Thromb Haemost, 0;15(7):1463-1472.  0
  28. Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer.
    Authors: Willuda J, Linden L, Lerchen H, Kopitz C, Stelte-Ludwig B, Pena C, Lange C, Golfier S, Kneip C, Carrigan P, McLean K, Schuhmacher J, von Ahsen O, Muller J, Dittmer F, Beier R, El Sheikh S, Tebbe J, Leder G, Apeler H, Jautelat R, Ziegelbauer K, Kreft B
    Mol Cancer Ther, 0;16(5):893-904.  0
  29. Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening.
    Authors: Krausz E, de Hoogt R, Gustin E, Cornelissen F, Grand-Perret T, Janssen L, Vloemans N, Wuyts D, Frans S, Axel A, Peeters P, Hall B, Cik M
    J Biomol Screen, 0;18(1):54-66.  0
  30. Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns.
    Authors: Stadem P, Hilgers M, Bengo D, Cusick S, Ndidde S, Slusher T, Lund T
    PLoS ONE, 0;12(2):e0172980.  0
  31. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
    Authors: Jones B, Kelley L, Loskutov Y, Marinak K, Kozyreva V, Smolkin M, Pugacheva E
    Mol Cancer Res, 0;15(6):670-682.  0
  32. The nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.
    Authors: Zhu B, Ferry C, Markell L, Blazanin N, Glick A, Gonzalez F, Peters J
    J Biol Chem, 0;289(29):20102-19.  0

FAQs

  1. What kinds of tumor cells or biopsy specimens grow in vivo with Cultrex® BME?

    • Many cell lines and tumor biopsy specimens (usually cut into small fragments) have been found to grow in vivo when implanted with Cultrex® BME. These include melanoma, intestinal, prostate, breast, lung, renal, and liver cancers as well as the 3T3 mouse embryonic fibroblast cell line.

  2. How does Cultrex® Basement Membrane Extract (BME) promote cell differentiation?

    • All epithelial and endothelial cells are in contact with a basement membrane matrix on at least one of their surfaces. By providing them with their natural matrix in vitro as a substrate for the cells that provides biological cues, the cells can assume a more physiological morphology (i.e. correct shape) and begin expression of cell-lineage specific proteins. Two-dimensional plastic surfaces, in combination with serum-containing media, cause cells to flatten, proliferate and de-differentiate.

  3. How should Cultrex Basement Membrane Extract (BME) be stored and handled?

    • Cultrex BME should be stored at or below -20°C for optimal stability. Preparation of working aliquots is recommended. Cultrex BME should be thawed overnight on ice at 4°C, however long term storage at 4°C is not recommended. Freeze/thaw cycles and gel-liquid phase transitions should be avoided, since they can compromise product integrity.

View all FAQs

Reviews for Cultrex Basement Membrane Extract, PathClear

Average Rating: 5 (Based on 3 Reviews)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Cultrex Basement Membrane Extract, PathClear?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Cultrex PathClear Basement Membrane Extract (2 x 5 mL)
By Anonymous on 08/20/2018
Application: In vivo study

Cultrex PathClear Basement Membrane Extract
By Anonymous on 04/01/2018
Application: Cell migration/motility

Cultrex PathClear Basement Membrane Extract
By Anonymous on 04/01/2018
Application: CellProlif